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Abstract
We have identified a novel component of the circadian clock that regulates its sensitivity to light at the evening light to dark
transition. USP2 (Ubiquitin Specific Protease 2), which de-ubiquitinylates and stabilizes target proteins, is rhythmically
expressed in multiple tissues including the SCN. We have developed a knockout model of USP2 and found that exposure to
low irradiance light at ZT12 increases phase delays of USP2
2/2 mice compared to wildtype. We additionally show that
USP2b is in a complex with several clock components and regulates the stability and turnover of BMAL1, which in turn alters
the expression of several CLOCK/BMAL1 controlled genes. Rhythmic expression of USP2 in the SCN and other tissues offers a
new level of control of the clock machinery through de-ubiqutinylation and suggests a role for USP2 during circadian
adaptation to environmental day length changes.
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Introduction
Core clock function in mammals depends on the expression and
function of several clock components including CLOCK, BMAL1,
the PERs, the CRYs, REV-ERBa, and RORa. During a 24-hour
cycle, CLOCK and BMAL1 (ARNTL) heterodimerize and induce
the transcription of target genes by binding to E-box elements
within their promoter regions [1,2,3]. Pers, Crys, Rev-erba and RORa
are all targets of CLOCK/BMAL1 transactivation. REV-ERBa
can directly inhibit Bmal1 expression while PER and CRY
complex formation and nuclear re-entry can inhibit CLOCK/
BMAL1 induced transcription [1,2,4]. Several additional protein
interactions and modifications are required for maintenance of the
circadian clock. For example, CK1ed phosphorylation of PER1
has been shown to precede PER1 degradation via SCFb
TRCP E3
ubiquitin ligase targeting [5]. Hence, protein modifications
affecting protein stability are essential for fine-tuning the molecular
circadian cycle.
Mammals regularly adapt to changing environments by resetting
the endogenous pacemaker in the suprachiasmatic nuclei (SCN) of
the hypothalamus. Clock resetting by light involves signaling
initiated in the retina and passed via intrinsically photosensitive
ganglion cells (ipGCs) to the SCN [6]. Glutamate and PACAP
(pituitary adenylate cyclase activation peptide) released from the
ipGC terminals induce Ca
2+ release in the SCN causing multiple
changes including phosphorylation of CREB, which binds CRE-
elements to induce Per1 and Per2 expression [7,8]. Several clock
components can be phosphorylated, sumoylated or ubiquitinylated
and degraded through the proteasome pathway [9,10,11]. For
example, it has been reported that BMAL1 ubiquitinylation follows
sumoylation, and is required for BMAL1 transactivation and
subsequent degradation[10].Furthermore, anubiquitinligaseplays
a role during light resetting in Drosophila [9,10,11,12], suggesting
that ubiquitinylation and de-ubiquitinylation may have a role in
responses to light in mammals. Nonetheless, the role of post-
translational modifications of clock components in entrainment to
light in the SCN is not well understood.
We have identified a circadian de-ubiquitinating enzyme called
USP2 (Ubiquitin Specific Protease 2) with peak mRNA expression
at ZT12 in mouse [13] that was later found to be under CLOCK/
BMAL1 transcriptional control in SCN [14]. We engineered a
targeted mutation of USP2 in mice and found that they exhibit
enhanced phase delays at low irradiance levels that have little or
no effect on wildtype mice. USP2 forms protein complexes with
several clock components, including BMAL1 and can influence
the abundance and turnover of BMAL1. Our analysis suggests
that USP2 associates with clock protein complexes and stabilizes
BMAL1, which in turn regulates sensitivity to early evening light
exposure through its effects on transcription of CLOCK/BMAL1
regulated genes.
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Expression and Oscillation of Usp2 in SCN, Retina and
Liver
Previous studies [15] have identified two isoforms of Usp2 that
are produced by alternative splicing; a 69-kDa protein (Ubp69 or
USP2a) and a 45-kDa protein (Ubp45 or USP2b). Although
studies have reported that Usp2 exhibits a highly robust circadian
expression pattern in liver and SCN [13,14], those studies did not
directly compare the two transcripts. Our data show that both
forms exhibit rhythmic expression profiles at both the mRNA and
protein level. However in its temporal expression, Usp2b is the
dominant circadian form, exhibiting a peak at ZT8 in liver and
ZT12 in SCN and retina (Fig. 1A). Both USP2a and USP2b
protein expression changes over time in SCN, but USP2b appears
to be more abundant (Fig. 1B). Expression of both USP2a and
USP2b is higher at night and early morning (ZT16-ZT0) yet each
is detectable in the SCN throughout the day (Fig. 1B).
Generation and Characterization of the USP2
2/2 Mice
We hypothesized that USP2 plays a central role in the circadian
clock mechanism. To directly test that idea, we targeted the
deletion of exons 3 and 4, which encode a portion of the catalytic
region of the enzyme common to both isoforms, and inserted a
stop codon (Fig. 2A). The deletion was confirmed in stem cells
(Fig. 2B) and in germ line mice (Fig. 2C) by southern blotting.
Western blotting from USP2
2/2 total retina lysate using an
antibody generated against the C-terminal region of USP2 showed
that USP2a was undetectable. However, we did detect low levels
of immunoreactivity at about 45 kDa in USP2
2/2 retina (Fig. 2D).
This could reflect a cross-reactivity or a modified USP2 protein.
We used RT-PCR with Usp2a- and Usp2b-specific primers to
determine if any mutant transcripts were produced in retina, liver,
and SCN. We failed to detect a transcript using primers for Usp2a,
but the Usp2b primers did reveal a low-abundance transcript. This
transcript was cloned and cDNA sequencing not only confirmed
the effectiveness of our deletion strategy (Fig.2a) but also showed
that Exon 1 of the wildtype Usp2b transcript (Ensembl Gene
Identifier ENSMUST00000065461) was alternatively spliced in
frame to Exon 5 (see Fig. 2A). These data confirm that a transcript
lacking the deleted Exons but encoding the C-terminal antibody-
binding site is present at low levels in USP2
2/2 mice.
Behavioral Characterization of USP2
2/2 mice
To understand whether USP2 is required for normal circadian
function, we used cages equipped with running wheels to
determine free-running behavior of USP2
+/+ and USP2
2/2 mice
in constant darkness (DD) following a period of 12-hour light/dark
(LD). Free-running periods measured in USP2
2/2 mice were
indistinguishable from USP2
+/+ mice (Fig. 3A–B). Although
period differences were not found, USP2
2/2 mice were
significantly more active during subjective night when maintained
in DD (Fig. 3C).
Ubiquitinylation by the ubiquitin ligase JETLAG in Drosophila
plays a role during light resetting [12]. We therefore asked whether
mice deficient in de-ubiquitinylation by USP2 might also exhibit
altered circadian sensitivity to light. First, USP2
+/+ and USP2
2/2
mice housed in 12-hour LD were placed in constant light (LL) of
low irradiance (,5–20 mW?cm
22) and every 10 days the
irradiance was increased (Fig. 4A, arrows). As expected, LL
Figure 1. Rhythmic expression of USP2a and b in SCN, retina and liver. A. Usp2a and
Usp2b mRNA from liver, SCN, and retina of WT C57BL/6
mice kept on a 12-hour LD schedule. Usp2a and Usp2b transcripts were measured by RT-qPCR, expression was normalized to RNA Polymerase II and
analyzed using the DCT method. The peak was standardized at 100%. The time of day is indicated on the X-axis and with bars. Both transcripts are
rhythmic in the liver, SCN, and retina and asterisks signify statistical significance using one-way ANOVA (*p,0.05, **p,0.005, ***p,0.001). B.
Rhythmic USP2a and USP2b protein levels from SCN of WT C57BL/6 mice housed in LD with c-tubulin as loading control.
doi:10.1371/journal.pone.0025382.g001
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decreased rhythmic activity in both USP2
+/+ and USP2
2/2
animals. However, USP2
2/2 mice were strikingly different than
wild type. Their period length increased slowly in response the
lower irradiance levels, and, more strikingly, they appeared to
exhibit a dramatic delay in activity onset at the lowest irradiance
tested. This suggested that the lowest irradiance (,5–
20 mW?cm
22) was sufficient to cause a phase delay but not
sufficient to increase the period length as is expected in LL
conditions and as is shown by the control animals.
To determine if loss of USP2 indeed altered the minimum
irradiance needed to induce a phase delay at the light-dark
Figure 2. Targeted deletion of Exons 3 and 4 of the Usp2 gene. A. A diagram of a portion of the Usp2 gene is illustrated at the top with Exon
numbering based on Ensembl Gene structure of Usp2a (Usp2–201- ENSMUT00000034508). The targeting vector was constructed to introduce LoxP
sites upstream and downstream of Exons 3-4 as well upstream of the thymidine kinase (TK) neomycin (NEO) cassette. The structure of Usp2b (not
shown) begins with an alternative Exon 1 and Exons 3–4 correspond to Exons 2–3 in Usp2b (Usp2-202-ENSMUST00000065461). Transient transfection
of targeted ES cells with a plasmid encoding Cre recombinase was expected to produce cells carrying a conventional KO allele with a single LoxP site
replacing exons 3 and 4 with insertion of a stop codon [39]. Cre expression was also expected to produce a ‘‘floxed’’ allele (not illustrated) with LoxP
sites in Intron 2–3 and 4–5 with deletion of the TK-Neo cassette [39]. Three Southern blot strategies for determining correct targeting involved
restriction digests with enzymes (color coded) at the relative positions indicated in each diagram. Note that the BamH1 site 59 of Exon 3 and BstZ17I
site 39 of Exon 4 (each marked by an asterisk) were deleted from the wildtype gene by the targeting strategy. The probe used in the Southern blots in
B and C covered a region spanning spanning Exons 9 through 11 (not shown in the diagrams). B. Southern blots of BstZ17I-Xba1 (coded green)
digests from five sets of heterozygous stem cells obtained after Cre recombinase transfection and used to generate chimeric mice in the Medical
College of Wisconsin transgenic facility. Owing to the loss of a BstZ17I site during targeting the conventional KO allele (3490 bp) is larger than the
wildtype allele (2424 bp) using this enzyme pair. C. Germ line transmission in mice was obtained only for the conventional KO and is shown by
Southern blotting of individual USP2
+/+, USP2
+/2 and USP2
2/2 mice using 3 different restriction digest strategies (Pst1; coded blue, BstZ17I-Xba1;
coded green, and BamH1-HindIII; coded orange). Expected sizes of labeled DNA fragments for WT and KO alleles are indicated below each of the
three blots. The size of the targeted allele in the BstZ17I-Xba1 and BamH1-HindII digests is caused both by loss of Exons 3 and 4 and loss of a BstZ17I
and BamH1 site during targeting. The structure of the targeted allele was verified by genomic DNA sequencing. D. Western blot for USP2b and c-
tubulin from the retina USP2
+/+ and USP2
2/2 mice at ZT12. USP2a protein was undetectable in USP2
2/2 mice, but a faint immuno-reactive band is
seen in the USP2
-/- lane.
doi:10.1371/journal.pone.0025382.g002
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+/+, USP2
+/2 and USP2
2/2 mice were entrained
to LD conditions and at the beginning of expected light offset
(ZT12) exposed to 4-hours of low irradiance light (ZT12–16)
followed by 7 days in darkness (DD) (Fig. 4B–C, arrows). They
were then re-entrained to the 12-hour LD cycle for a week and the
experiment was repeated with light of higher irradiance. USP2
2/2
mice displayed enhanced sensitivity to light (Fig. 4C) at low
irradiance levels (Log irradiances 2.5 and 3 which correspond to
,0.05 mW?cm
22 and ,0.1 mW?cm
22) and heterozygotes exhib-
ited intermediate phase delays between those of WT and USP2
2/2
animals (Fig. 4C). Although this trend was apparent across the
full range of light levels tested, statistically significant differences
were detected only at the lower two irradiance levels in which
wild type mice either failed to exhibit any phase shift (Log
irradiance 2.5) or exhibited moderate phase shifts (Log irradiance
3). To rule out an influence of genotypic differences in phase
angle of entrainment on measured phase shifts this parameter was
determined in mice entrained to an LD cycle as above and then
released into DD, and differences were not found. Furthermore,
the increased sensitivity to light was specific to the paradigm in
which light was extended by 4 hours at the time of light off-set
(ZT12). Phase shifting was not significantly different in USP2
+/+
and USP2
2/2 mice in response to 4 hours of light beginning at
either ZT14 or ZT21 (Fig. 4D).
Altered Clock gene expression in USP2
2/2 mice
We next asked whether the expression of core elements of the
molecular clock were altered in the SCN or liver of USP2
2/2
mice. The rationale was that such disruption would be expected if
USP2 functions within the molecular clock. We began with a
quantitative PCR analysis of multiple clock gene mRNAs at
different times in an LD cycle (Fig. 5). Using two-way ANOVA for
comparison of the patterns seen in USP2
++ and USP2
2/2 mice we
found that the phase of the peak of Per1 and Cry1 expression is
4 hours earlier in USP2
2/2 SCN. On the other hand, the peak
expression of both Bmal1 and Dbp was 4 hours later in USP2
2/2
liver. Hence, the phasing of expression of some clock components
is altered in different ways in USP2
2/2 SCN and liver. Although
these differences suggest that loss of USP2 alters clock activity, it
provides no insight into how those changes are mediated.
USP2 encodes de-ubiquitinylating enzymes that stabilize target
proteins by removing the ubiquitins of K48-linked chains that flag
proteins for proteasomal degradation [16]. Therefore, reduced or
altered expression of proteins in USP2
2/2 mice would provide
clues to understanding the molecular targets of USP2 within the
clockwork. We began by determining relative PER1 and BMAL1
protein abundance by western blotting in extracts of micro-
dissected SCN over the course of a day from mice housed in LD
(Fig. 6A and B). First, BMAL1 appeared to be down-regulated in
USP2
2/2 mice at all time points except ZT20. However, the
reduction was statistically significant only at ZT8 and 12 (Fig. 6A,
right). PER1 was also significantly reduced at ZT8 and ZT12 and
its peak abundance was delayed to ZT16 (Fig. 6B, right). These
data indicate that both PER1 and BMAL1 are reduced in the
SCN at ZT12 when USP2
2/2 mice are highly sensitive to light-
induced phase delays.
Decreased PER1 and BMAL1 expression in the SCN of
USP2
2/2 mice suggests that USP2 might directly interact with
protein complexes containing BMAL1 and PER1. To test this we
used co-immunoprecipitation to look for protein complexes in wild
type SCN protein extracts containing both clock proteins and
USP2b, the more abundant USP isoform. We found that anti-
BMAL1 and anti-USP2 both co-precipitated small amounts of
USP2b along with CRY1, BMAL1 and CK1e (Fig. 6C). In
addition, anti-PER1 precipitated complexes with increased
relative amounts of BMAL1 and USP2b (Fig. 6C), while CRY1
Figure 3. Loss of USP2 does not alter circadian period. A. Representative double plotted wheel running records for age matched USP2
+/+ and
USP2
2/2 mice over 33 days (Y-axis). Mice were initially on a 12-hour LD cycle, followed by a free-run period in DD from day 15 onward (arrow). Data
were collected using ClockLab
TM software. B. The median period measured in USP2
+/+ mice (n=5) is 23.53 hours and the 23.68 hours in USP2
2/2
mice (n=6). The box represents the percentiles from 25
th to 75
th and the vertical whiskers represent the maximum and minimum periods measured
for each genotype. C. Activity counts per 24 hours measured by running wheel revolutions are plotted for USP2
+/+ (n=3) and USP2
2/2 (n=5) mice
housed in constant darkness. The bars are the mean 6 SEM and individual data points are plotted for each set; the median activity in USP2
+/+ mice
was 7341 revolutions/24 hours compared to 17,147 in USP2
2/2 mice. The asterisk signifies a significant difference using the un-paired t-test (p,0.05).
doi:10.1371/journal.pone.0025382.g003
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(Fig. 6C). These data indicate that SCN extracts contain native
protein complexes containing USP2b, BMAL1, PER1 and other
clock proteins. Interestingly, anti-ubiquitin antibodies co-precipi-
tate CRY1 with larger amounts of BMAL1, CK1e and USP2b
and each protein migrates at its normal molecular weight. This
implies that additional ubiquitinylated proteins or ubiquitin chains
coexist in complexes containing native, non-ubiquitinylated clock-
proteins.
BMAL1 turnover in the presence and absence of USP2b
Down-regulation of PER1 and BMAL1 in USP2
2/2 mice and
the presence of USP2b in native clock protein complexes
containing PER1 and BMAL1 suggests that USP2b may de-
ubiquitinylate and stabilize either PER1 or BMAL1. If USP2b
targets PER1 or BMAL1 one would predict that increasing
expression of USP2b would increase PER1 or BMAL1 stability
and abundance. To test this, increasing concentrations of a FLAG-
USP2b construct was transiently transfected into HEK293 cells
along with a constant amount of a bicistronic construct expressing
FLAG-GFP and MYC-BMAL1. We used one-way ANOVA to
ask whether target protein increased significantly with increasing
FLAG-USP2b. We found that MYC-BMAL1 rose in parallel with
USP2b (Fig.7A), and that the abundance of FLAG-GFP as a
control remained nearly constant (Fig. 7A). In contrast, co-
expression of increasing amounts FLAG-USP2b with MYC-
CLOCK or MYC-PER1 had no significant effect on their protein
abundance (Fig. 7B and C). These data indicate that USP2b can
stabilize BMAL1, but not PER1 or CLOCK.
To verify these results we used a second approach in which
turnover of target, MYC-tagged proteins was determined in the
presence or absence of USP2b (Fig. 7D-F). Each MYC-tagged
Figure 4. USP2
2/2 mice are more sensitive than wildtype to low irradiance light at ZT12. A. Wheel running records from USP2
+/+ and
USP2
2/2 mice in constant light. Plots represent the mean activity recorded in USP2
+/+ (n=7) and USP2
2/2 (n=8) mice. Mice were initially housed in
LD (,60–120 mW/cm
2) and transitioned to LL (top arrow, left) at ZT12 using low irradiance light (,5–20 mW/cm
2). Every 10 days (at each arrow, top
to bottom) the irradiance was increased sequentially to 30–60, 50–100, 60–120, and ,100–160 mW/cm
2. The white band between the lower 2 arrows
is a period when activity was not recorded due to a computer error. B. Mice were housed in LD for 7 days followed by a 4-hour dim light treatment
(Log irradiance 2.5, 0.05 mW/cm
2) beginning at the time of light offset and followed by a 7 day free-running period in DD to monitor the resulting
phase shift. Mice were returned to LD for 7 days and the experiment was repeated with light of higher irradiance (i.e., Log irradiance 3, 4, 4.5 and 5);
Log 5 corresponded to an irradiance of 9 mW/cm
2. The plots are the mean activity of 5 mice for each genotype. C. Irradiance response relationship for
USP2
+/+ (thin line), USP2
2/2 (thick line), and USP2
+/2 mice (dashed-line). Phase shifts following each light treatment was compared between USP2
+/+
and USP2
2/2 mice (**p,0.005, ***p,0.001, un-paired t-test). D. Phase shifts measured at Log irradiance 3 and Log irradiance 5 following 4 hours of
light at ZT12 (same data as in C) compared to treatments beginning at ZT14 and ZT21 for USP2
+/+ (black bars) and USP2
2/2 (white bars) mice.
Significant differences (p.0.05) between genotype were not detected at ZT14 or ZT21.
doi:10.1371/journal.pone.0025382.g004
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or FLAG-GFP and after 24 hours protein synthesis was inhibited
with cycloheximide and abundance of the MYC-tagged protein
was measured over time. Consistent with the effect of increasing
FLAG-USP2b (Fig. 7A), the turnover of BMAL1 was delayed in
the presence of FLAG-USP2b (Fig. 7D). Using regression analysis
we estimated that the half-life of MYC-BMAL1 was about
3.9 hours and significantly (p,0.05) increased to greater than
8 hours in the presence of USP2b. In contrast, USP2b did
not significantly (p.0.05) delay turnover of MYC-CLOCK or
MYC-PER1 (Fig. 7E and F). Given that BMAL1 is down-
regulated in USP2
2/2 SCN (Fig. 6A) and that its stability is
altered by over-expression of USP2b in both assays (Fig. 7A and
D) our data suggest that BMAL1 is a likely protein target of
USP2b.
Co-precipitation of USP2b and BMAL1 and
de-ubiquitinylation by USP2b
To determine if USP2b alters the ubiquitinylation state of
proteins in complex with BMAL1, we co-expressed HA-ubiquitin
and the bicistronic construct expressing FLAG-USP2b and MYC-
BMAL1; as a control we used the FLAG-GFP and MYC-BMAL1
bicistronic construct. We then immunoprecipitated using FLAG or
MYC antibodies and analyzed for the presence of BMAL1 (MYC),
GFP or USP2b (FLAG), and ubiquitin (HA) (Fig. 8A–C). We first
determined that transfection of the FLAG-GFP and MYC-
BMAL1 or the FLAG-USP2b and MYC-BMAL1 initially resulted
in similar expression levels of MYC-BMAL1 (Fig. 8A). In the
control immunoprecipitations (Fig. 8B, left) the FLAG antibody
did not pull down MYC-BMAL or HA-Ubiquitin, but the MYC
antibody did pull down MYC-BMAL1. In the experimental group
(Fig. 8B, right) both FLAG and MYC antibodies co-precipitated
MYC-BMAL1 and FLAG-USP2b as expected if USP2b and
BMAL1 were present in the same protein complex. In addition,
the HA antibody immunoprecipitated FLAG-USP2b, which is
consistent with the fact that USP2b can bind to ubiquitin chains.
Finally, the MYC-BMAL1 blot in Figure 8B was re-probed with
the HA antibody. This generated a smear above the BMAL1
bands in control IPs, but not when BMAL1 was co-expressed with
USP2b (Fig. 8C). Thus, the ubiquitinylation of proteins in complex
with MYC-BMAL1 was reduced in the presence of USP2b. Taken
together with the altered stability and abundance of BMAL1 in the
presence of USP2b, this suggests that BMAL1 is a target of
USP2b.
Light resetting in BMAL1
+/2 and USP2
+/2/BMAL1
+/2 mice
Since USP2 expression is under circadian control [14]
downstream of CLOCK/BMAL1, our work identifies a novel
feedback loop at the protein level that would be expected to
stabilize BMAL1. However, since USP2 is likely to have
multiple targets the relationship between USP2 and BMAL1
does not necessarily explain the enhanced phase delays observed
in USP2
2/2 mice. As a preliminary test of the hypothesis that
altered BMAL1 abundance or turnover in USP2
2/2 mice
contributes to the enhanced phase delays at low irradiance, we
conducted phase shift experiments like those in Figure 4B using
BMAL1
+/2 and BMAL1
+/2/USP2
+/2 mice (Fig. 9). BMAL1
heterozygotes express BMAL1 at about half the level of wildtype
mice [17], which is comparable to the reduction seen in SCN of
USP2
2/2 mice at ZT8 and ZT12 (Fig 6A, right). These mice
also exhibited significantly enhanced phase delays compared to
wildtype in response to light exposure beginning at ZT12
(Fig. 9A–C). However, this was not a precise phenocopy of
the USP2
2/2 effect because the enhanced response was
modest at low irradiance (Log irradiance 2.5 and 3) and was
more pronounced at higher irradiance (Log irradiance 4 and
4.5).
In contrast, USP2/BMAL1 double heterozygotes were signif-
icantly more sensitive to low irradiance light (Log irradiance 2.5
and 3) compared to wildtype, and as in the case of USP2
2/2 mice,
the difference between WT and double heterozygotes was not
significant at higher irradiance (Fig. 9C). In response to the two
lowest light levels double heterozygotes showed an average phase
delay of 38 and 12 minutes less, respectively, than USP2
2/2 mice
Figure 5. Altered temporal mRNA expression of clock genes in
USP2
+/+ and USP2
2/2 SCN and liver. Per1, Per2, Cry1, Rev-erba,
Bmal1, and Dbp was measured by RT-qPCR and normalized to RNA
polymerase II expression in SCN and liver isolated every 4 hours from
USP2
+/+ (solid line) and USP2
2/2 (dashed line) housed in a 12-hour LD
cycle. The data was analyzed using the DCT method and peak mRNA
expression was standardized at 100%. Data points are mean 6SEM
(n=3 animals for each genotype). Two way ANOVA shows significance
differences in the rhythms between wildtype and USP2
2/2 mice
(asterisks) for Per1 and Cry1 in SCN as well as BMAL1 and Dbp in liver
(*p,0.05, ***p,0.001, two-way ANOVA).
doi:10.1371/journal.pone.0025382.g005
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2/2 mice
at low irradiance (compare Fig. 9C and Fig. 4C). The enhanced
phase shifts in both BMAL1
+/2 and BMAL1
+/2/USP2
+/2 mice
suggest that BMAL1 in USP2
2/2 mice is at least partially
responsible for the enhanced phase delays.
Molecular clock function in USP2
2/2 SCN
How could increased BMAL1 turnover in USP
2/2 mice
contribute to the light sensitivity phenotype that we have
described? An important clue comes from the finding that it is
the ubiquitinylated form of BMAL1 that is transcriptionally active
[10] and that transcriptional activity is closely coupled to BMAL1
turnover [9,10]. Thus, increased ubiquitinylation and turnover of
BMAL1 at the light to dark transition could lead to the increased
transcription of CLOCK/BMAL1 regulated genes such as Per1
that are known to be directly involved in delay phase shifts
specifically in the lighting paradigm used in our studies. To test
this we measured the pre-mRNA expression levels of the
CLOCK/BMAL1 controlled genes (Per1, Dbp and Rev-erba)i n
USP2
+/+ and USP2
2/2 SCN during exposure to early evening
low irradiance light (Fig. 10A). We used RT-qPCR with primers
designed for un-spliced mRNA rather than processed mRNA
because those transcripts are closer to the immediate event of
CLOCK/BMAL1 induced transcription. We used c-Fos as a
Figure 6. Clock component expression and association with USP2. A–B. SCN was micro-dissected every 4 hours from USP2
+/+ (left) and
USP2
2/2 mice (right) housed in LD. SCN lysate from 5 mice at each time point was pooled (20 mg of protein) and western blotted using either anti-
BMAL1 (A) or anti-PER1 (B) and anti-c-tubulin antibodies. Band densities were acquired with ImageJ software and plots to the right are mean band
density 6SEM for BMAL1 (n=4) or PER1 (n=3) normalized to c-tubulin in either USP2
+/+ (black bars) or USP2
2/2 SCN (white bars). Asterisks signify a
significant difference (p,0.05) using an un-paired t-test. C. Immunoprecipitation (IP) of WT C57BL/6 micro-dissected and pooled SCN extracts (N=15)
at ZT12. IP was performed using protein A beads conjugated with either anti-BMAL1, -USP2, -ubiquitin, -PER1, -CRY1, -CK1e, or –EGFR rabbit
antibodies. IP antibodies are indicated across the top. Western blotting of total lysate (10 mg) and IP samples was performed using rabbit-anti-PER1,
rabbit-anti-CRY1, guinea pig-anti-BMAL1, rabbit-anti-CK1e, rabbit-anti-EGFR, or guinea pig-anti-USP2 antibodies that were different from the IP
antibodies. Western antibodies are indicated at left. Arrowheads mark the expected size of either BMAL1 or USP2b.
doi:10.1371/journal.pone.0025382.g006
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pathway that does not involve CLOCK/BMAL1 [18,19]. Per1,
Rev-erba, and Dbp pre-mRNA were all significantly increased (2–4
fold) in the SCN of USP2
2/2 mice compared to controls (USP2
+/+)
within 2 hours of low irradiance light (Log irradiance 3) initiated at
ZT12, while the pre-mRNA of the immediate early gene, c-Fos, was
unaffected (Fig. 10A). These data suggest that at the molecular level,
the transcriptional activity of CLOCK/BMAL1 in the SCN is
enhanced specifically in USP2
2/2 mice during the low irradiance
light treatment.
Figure 7. BMAL1, CLOCK and PER1 abundance in the presence of USP2b. A-C. Increasing FLAG-USP2b plasmid (0–1 mg) was co-transfected
in HEK293 cells with constant (1 mg) bicistronic plasmid encoding FLAG-GFP along with MYC-BMAL1 (A), MYC-CLOCK (B), or MYC-PER1 (C). FLAG-
GFP is constant in each lane but as the concentration of FLAG-USP2b construct increased more MYC-BMAL1 (A) was also detected. Plots to the right
of each western blot are mean +SEM (N=3) band density of FLAG-USP2b (squares) or MYC-BMAL1 (circles) (A), CLOCK (B), or PER1 (C). Band densities
were normalized to FLAG-GFP as a function of amount of FLAG-USP2b plasmid. One way-ANOVA was used to determine if target protein changed as
a function of increasing USP2b. Bars connect points on the plot for BMAL1 that are significantly different from each other and asterisks signify p
values (***p,0.0001 and **p,0.001). D–F. A bicistronic vector encoding either FLAG-GFP along with MYC-BMAL1 (D, left), CLOCK (E, left), or PER1
(F, left), or FLAG-USP2b along with the same target protein (D–F, right) was transfected into HEK293 cells. After 24 hours the cells were incubated
with cycloheximide (20 mg/ml) for the indicated periods of time (X-axis). Western blotting of total protein lysates with anti-MYC was used to measure
the levels of MYC-BMAL1, -CLOCK, and -PER1. Plots below Western blots are mean +SEM for three independent experiments in which target protein
band density was normalized to that of c-tubulin as a function of time in cycloheximide. Solid lines represent co-expression of target protein with
FLAG-GFP and dashed lines are with FLAG-USP2b. We used regression analysis to estimate BMAL1 half-life in the absence of USP2b and found that
value (3.9 hrs) significantly (p,0.05) increased to greater than 8 hrs in the presence of USP2b. Significant changes were not seen for CLOCK or Per1.
doi:10.1371/journal.pone.0025382.g007
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experimental (FLAG-USP2b/MYC-BMAL1) bicistronic vectors in NIH 3T3 cells. Un-transfected lane shows cross-reactivities in the absence of specific
antigen. B. Reciprocal co-IP of FLAG-USP2b and MYC-BMAL1 and of USP2b with HA-UB in experimental (right) and control (left) transfections. C.
Upper blot in B re-stained with anti-HA-UB to detect ubiquitinated BMAL1 (arrows) in control (left) and its absence in experimental (right)
transfection. In B and C the middle lane (arrowhead) contains MW markers.
doi:10.1371/journal.pone.0025382.g008
Figure 9. Enhanced sensitivity to light in BMAL
+/2 and USP2
+/2/BMAL
+/2 mice. A–B. Mice were housed in LD for 7 days followed by a 4-
hour delay in light offset (arrows) and a 7 day free-running period in DD to monitor phase shifts. Mice were then returned to LD and the experiment
was repeated with light of a higher irradiance. Actograms shown are averages of 5 individual mice for each genotype. C. In this plot phase delays in
excess of those in wildtype controls are plotted as the mean "enhanced" phase delay for each mutant genotype (mutant phase delay minus wildtype
phase delay) at log irradiance 2.5 (black bars), 3 (grey bars), 4 (light grey bars), and 4.5 (white bars). Means for each genotype exceeded wildtype
except for the double heterozygotes at the highest irradiance. Un-paired t-tests were used to compare phase shifts between BMAL1
+/2 or USP2
+/2/
BMAL1
+/2 and the wildtype at each irradiance as follows: Log irradiance 2.5; BMAL1
+/2 and USP2
+/2BMAL1
+/2 mice exhibit significant delays in
excess of wild type (*p,0.05 and **p,0.005). Log irradiance 3; USP2
+/2/BMAL1
+/2 mice phase delayed significantly more than wild type (*p,0.05).
Log irradiance 4 and 4.5; BMAL1
+/2 mice phase delay significantly more than wild type (***p,0.0001).
doi:10.1371/journal.pone.0025382.g009
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BMAL1 or PER1 protein was altered in response to the same
light exposure. Western blotting for BMAL1 from protein lysates
isolated from USP2
+/+ and USP2
2/2 SCN showed no statistically
significant effect of low irradiance light but did confirm our earlier
data (Figure 6A) that BMAL1 is less abundant in USP
2/2 mice
(Fig. 10B, graph). The striking finding in these experiments was
that after 2 hours of low irradiance light PER1 protein was nearly
undetectable in the SCN of wildtype mice (Fig. 10B, left). This
unexpected and previously un-reported finding contrasts sharply
with the finding that in USP2
2/2 mice PER1 protein was on the
rise over this time course in either light or darkness (Fig. 10B,
right). The decline in PER1 in low irradiance light in wildtype
mice is not consistent with a direct effect of USP2 on PER1 since
Figure 10. Clock controlled pre-mRNA and protein expression in SCN during low light at ZT12. A. Un-spliced mRNA transcripts for Per1
(Mean 6SEM, n=3 animals), Rev-erba (n=6), Dbp (n=6) and cFos (n=3) were measured by RT-qPCR from isolated SCN during exposure to low
irradiance light (log irradiance 3) from ZT12 to ZT16. Un-spliced mRNA was normalized to RNA Polymerase II and analyzed using the DCT method [40].
Changes in each pre-mRNA relative to the zero time point is plotted over time for USP2
2/2 (dashed line) and USP2
+/+ (solid line). (Asterisks indicate
time points where the difference between genotypes is significant (*p,0.05, two-way ANOVA). B. Western blots of PER1, BMAL1 and c-tubulin in
SCN samples at 0.5, 2 and 4 hrs in darkness or low light (log irradiance 3) from ZT12 to ZT16 for USP2
+/+ (left) and USP2
2/2 (right) mice. Plots below
each set of blots are the mean 6SEM (n=3) band density of PER1 and BMAL1 (normalized to c-tubulin) in USP2
+/+ (left) or USP2
2/2 SCNs at each of
three time points (0.5, 2 and 4 hrs) in darkness (black bars) or low light (grey bars). Note that in USP2
+/+ mice PER1 normally plummets (to barely
detectible levels by 2 hrs of low irradiance light and then rebounds. The horizontal bar connects the 2 hr time point in dark vs. light and the asterisk
signifies a significant difference (p,0.05, two-way ANOVA). In contrast, PER1 is on the rise across these time points in light or dark in USP2
2/2 mice.
Significant differences (p,0.05) in protein abundance between genotypes are indicated by asterisks in the plot on right. While BMAL1 abundance
does not change significantly with light treatment in either genotype, it is reduced in USP
2/2 SCNs (see also Figure 6A). Additionally, PER1 is lower at
0.5 hrs in darkness but higher a 2 hrs in light in the USP2
2/2 SCNs. C. Schematic depicting the expected effects of increased or decreased USP2 on
target protein (i.e., BMAL1) ubiquitinylation state and abundance. BMAL1 is depicted as being in an equilibrium between enzymes promoting its yet
unidentified ubiquitinylation (E3 ligase) and USP2, which promotes its de-ubiquitinylation. Over expression of USP2b would swing the equilibrium to
the left stabilizing BMAL1 with less ubiquitin. Loss of USP would swing the equilibrium to the right with reduced BMAL1 abundance and promote
higher turnover. Work by others indicates that ubiquitinylated BMAL1 is transcriptionally active but rapidly degraded [10]. Thus, loss of USP2 would
reduce BMAL1 levels but also increase its turnover and transcriptional activity. This would include CLOCK/BMAL1 regulated genes such as Per1.
doi:10.1371/journal.pone.0025382.g010
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thought that increasing PER1 is required for light-induced phase
shifts. Our data suggest that at low light levels, which normally
have little or no effect on phase in wild type animals, PER1
expression is actually declining. In contrast, the increased Per1
pre-mRNA (Fig. 10A) and rising PER1 protein (Fig. 10B) in
USP2
2/2 animals suggests that expression of PER1 is enhanced
during the low light signal, which in this case leads to a phase
delay. This suggests a scenario in USP2
2/2 mice in which
increased turnover of BMAL1 coincides with increased CLOCK/
BMAL1-driven gene expression in the USP2
2/2 SCN.
Although we often correlate protein abundance and stability
with functional activity, our data on BMAL1 are consistent with
other work indicating that it is the ubiquitinylated form of BMAL1
that is transcriptionally active [10] and that transcriptional activity
is closely coupled to BMAL1 turnover (Fig. 10C). [9,10]. Hence,
we suggest that increasing expression of Per1 and other CLOCK/
BMAL1 transcripts in USP2
2/2 mice compared to wild type
following low light might account for the enhanced phase delays
observed in USP2
2/2 mice.
Discussion
Our principal finding is that mice lacking the de-ubiquitinylat-
ing enzyme USP2 are hypersensitive to light at the day-to-night
transition, resulting in enhanced phase delays measured by wheel
running activity. Notably, the sensitivity to early evening light
exposure in USP2
2/2 mice is specific to light beginning at ZT12
and occurs at scotopic irradiances that do not normally cause
phase delays in wildtype animals. This suggests that USP2
negatively regulates its targets in the light-entrainment pathway,
specifically in response to day lengthening at low irradiance levels
corresponding to dusk. In other words, at least one USP2 target
reduces the sensitivity to light.
In theory USP2 could regulate sensitivity to light by altering the
response of the SCN to its light input or further upstream within
the retina or retinohypothalamic tract. Our finding that USP2b is
in complex with several clock components in the SCN, including
PER1 and BMAL1 suggests that altered expression of clock
components might account for the observed increased sensitivity to
light in USP2
2/2 mice. For example, altered clock function in the
USP2
2/2 mice might make them more susceptible to entrainment
signals at the day to night transition. Of particular relevance is our
finding that USP2b alters BMAL1 abundance and turnover.
Consequently, decreased BMAL1 abundance and increased
turnover in the absence of USP2 could account for the altered
expression of clock controlled genes and core clock components
observed. Furthermore, our finding that BMAL1/USP2 double
heterozygotes exhibit enhanced phase shifts in low irradiance light
suggests that the enhanced sensitivity phenotype seen in USP2
2/2
mice could be mediated at least in part by BMAL1. We propose
that BMAL1 mediates this effect through its interaction with
CLOCK. It is of interest that a similar phase shift paradigm in
CLOCK
2/2 mice causes a phase advance rather than delay [20].
How could reduced abundance and increased turnover of
BMAL1 enhance sensitivity to light? It has been reported that the
transcriptional activity of BMAL1 (e.g., CLOCK/BMAL1) is
closely coupled to its ubiquitinylation and turnover [10]. In this
regard, BMAL1 is one of a long list of transcription factors in
which transcriptional activity is closely coupled to ubiquitinylation
[21,22,23,24,25]. In these cases transactivation is tightly controlled
because the transcription factor itself is quickly degraded
immediately following trans-activation. In a preliminary evalua-
tion of this proposition we found that USP2
2/2 mice exhibited 2–
4 fold increases in the un-spliced, pre-mRNAs of three CLOCK/
BMAL1 controlled genes (Per1, Dbp, and Rev-erba) following low
irradiance light and these changes were not seen in wildtype
controls. We speculate that in the absence of USP2b, BMAL1
turns over more rapidly and that its ubiquitinylated form is
transcriptionally active prior to degradation (Fig. 10C). This
scenario becomes apparent in response to low irradiance light at
ZT12, when USP2b expression is normally on the rise. The
consequence is that targets of BMAL1/CLOCK transactivation
are enhanced in the absence of USP2b. Among these are PER1
and PER2 as well ryanodine receptors [26], all of which are
required for early evening phase delays.
Our data suggest that a functional relationship between USP2
and BMAL1 within the SCN could explain the enhanced phase
delays observed in USP2
2/2 mice. For example, early evening
phase shifts are thought to depend on light-induced changes in
intracellular Ca
++ within SCN, which results from BMAL1-
dependent transactivation, to control the abundance of ryanodine
receptors in SCN neurons [26]. However, we cannot rule out the
possibility that USP2 functions via regulation of BMAL1 at
another site within the retinohypothalamic tract because both
BMAL1 and USP2 are expressed in the retina and SCN.
Furthermore, other targets of USP2 within retina or SCN could
play a role in resetting. Currently, USP2a is known to de-
ubiquitinylate fatty acid synthase [27], MDM2 and MDMX
(mouse double minute 2 and X) [28] while USP2b is known to de-
ubiquitinylate the epithelial sodium channel in kidney [29] and
BMAL1 (our data). Other targets are possible within the clockwork
because USP2b is present in protein complexes containing clock
proteins. Although our initial survey suggests that neither CLOCK
nor PER1 are USP2b targets, other clock components were not
systematically evaluated. Our work has additionally focused on
USP2b because of our initial finding of its effect on BMAL1
stability. USP2a, however, is also a clock-controlled protein that
could control additional elements of the molecular clockwork.
The lowest irradiance level used in our experiments
(,0.05 mW?cm
22) is in the scotopic range and does not cause a
phase delay inwildtype miceinthe paradigm used inthis study. This
implies that light signaling normally associated with rod photore-
ceptors can cause phase resetting within the SCN and that USP2 is a
component of a gating system that regulates sensitivity of the
clockwork to early evening light. Recent studies in mice show that
rods mediate entrainment in the scotopic range via their signaling
through ipRGCs to the SCN [30,31]. The implied gating system
could operate at the level of the SCN, within the retinohypothalamic
tract or both. At the level of the SCN de-ubiquitinylation of BMAL1
by USP2b in wild type animals would be expected to reduce
BMAL1-dependent transactivation. Since this would include
reductions in Per1 and in the activity of ryanodine receptors [26],
which are required at the level of the SCN for light induced phase
delays, we speculate that the gating system operates at least in part at
the level of the SCN to render it less sensitive to its photic input.
Alternatively, a USP2-mediated activity within the retina could
regulate or filter signaling by rods through the system if ipRGCs.
Either or both gating systems could be of adaptive significance in
rodents at dusk by enabling a transition from cone-mediated day-
time vision to rod-mediated night-time vision without undue
alteration ofclockphasing through useofa rod pathwaytothe SCN.
Materials and Methods
Animals
Construction of the Usp2 targeting vector and the general
strategy for introducing LoxP sites upstream and downstream of
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neomycin (NEO) cassette (Fig. 2) was based on a previously
published targeting vector strategy [39]. The resulting targeting
construct was electroporated into R1 ES cells and after selection of
G418 resistant ES cell clones with correct targeting, the clones
were transiently transfected with a plasmid encoding Cre
recombinase [39]. This resulted in clones carrying a conventional
KO allele with a single LoxP site (Fig. 2A) and a ‘‘floxed’’ allele
with LoxP sites in intron 2–3 and 4–5 with deletion of the TK-Neo
cassette as verified by Southern blotting. These clones were
injected into blastocysts in the Medical College of Wisconsin
transgenic facility. Germ line transmission was obtained only for
the conventional KO allele (Fig. 2A–C).
All mice were maintained according to a protocol approved by
Institutional Animal Care and Use Committee at the Medical
College of Wisconsin (Protocol Number AUA00000032). Male
USP2
+/+ or USP2
2/2 mice were crossed with C57BL/6 mice and
were housed in LD conditions (ZT0=0600 hrs; ZT12=
1800 hrs). Male BMAL1
+/2 mice from Jackson Laboratories
were crossed with USP2
2/2 females. Mice were euthanized at
indicated times by CO2 (1L/min) followed by cervical dislocation.
Behavioral analysis
Wheel running experiments involved males (1–11 months old);
in each experiment the mice were age-matched. Mice were housed
individually in running wheel cages (Actimetics Inc, Evanston, IL)
on a 12-hour LD schedule with ad libitum feeding. Room
fluorescent lighting produced light levels of 60–120 mW/cm
2
depending on cage position, as measured with a radiometer
(International Light, Newberryport, MA) from within the cage. In
the constant light (LL) paradigm fluorescent light was attenuated
to 5–20 mW/cm
2 and every 10 days this was increased
sequentially to 30–60, 50–100, 60–120, and 100–160 mW/cm
2.
In phase shift experiments each cage was equipped with a white
LED that produced an un-attenuated irradiance (I) at the bottom,
center of the cage of ,9 mW?cm
22 (i.e., Log I 5.0) and neutral
density filters (Kodak) were used to attenuate irradiance to ,4.5
(Log I 4.5), ,0.9 (Log I 4.0), ,0.1 (Log I 3.0) and
,0.05 mW?cm
22 (Log I 2.5).
Wheel running activity was recorded and analyzed using
ClockLab
TM software (Actimetrics, Evanston, Il). Phase shifts
were calculated as the difference between the average onsets of
activity 5 days following the experimental light treatment and the
average onset of activity for the preceding 4 days. Mice were re-
entrained to 12-hour LD for 7 days before each subsequent
experimental light treatment.
Tissue Explants
SCN regions were removed by placing the brain in a matrix
device (Zivic Instruments, Pittsburgh, PA). 1 mm coronal sections
of the hypothalamus were removed and 0.5 mm60.5 mm
explants representing the SCN were micro-dissected and either
immediately frozen in liquid Nitrogen for protein analysis or in
RNA Later (Qiagen) for RNA analysis. Five SCN regions were
pooled for western blotting and one SCN region was used for each
RT-qPCR run. Retinal explants were obtained by micro-
dissection and immediately frozen in liquid nitrogen for western
blotting (10 retinas/sample) or stored in RNA Later for RNA
analysis (2 retinas/per sample). Liver was explanted
(1 mm61 mm), stored in RNA later, and used for RT-qPCR.
RT-qPCR using Qiagen reagents and a Bio-Rad iCycler PCR
unit was conducted according to detailed methods and with gene
specific primers described below.
Quantitative RT PCR
Ten mg of tissue in RNA later (Qiagen) was transferred to
500 ml of lysis buffer (RNeasy kit, Qiagen) and disrupted with a
Pellet Pestle homogenizer (Kontes) for 1 minute followed
trituration with an 18-gauge needle for 1 minute. The homogenate
was transferred to a Qiashredder spin column (Qiagen) and spun
at maximum speed for 2 minutes. RNA was isolated with an
RNeasy kit (Qiagen) according to the product protocol. Total
RNA was measured by spectrophotometry and diluted with ultra
pure H2O to a final concentration of 0.05 mg/ml. Resultant cDNA
using iScript cDNA synthesis kit (Bio-Rad) was diluted 1:5 in ultra
pure H2O and 5 ml was used per 25 ml total RT-qPCR reaction
(Bio-Rad iCycler). Each reaction was performed at 95u for 3
minutes, followed by 38 cycles of 30 seconds at 95u, annealing
temperature for 30 seconds, and 20 seconds at 72u. The optimized
annealing temperature for each primer pair was calculated from
the mean melting temperature of the primer pair. Forward and
reverse primers for Usp2 were:
Usp2a forward 59-GTCCCCGTCCCTGCTGCTCTCCAC-39,
Usp2a reverse 59- CATCTGTCGCCCCTTTTCTTCATCA-39
Usp2b forward 59- GGCCGCCCCCTGCTGAGAT-39,
Usp2breverse59-GAACGGCTGGCTGCTTGGTAGAGG-39.
Primers were optimized and the slopes of the standard curves
were ,3.2 6 0.5 with correlation coefficients equaling 0.99.
The remaining PCR primer sequences were obtained from
previously published work: Clock [32], Bmal1 [33], Per1 [34], Per2
[35], Cry1, Rev-erba, Dbp [36], pre-Per1 (courtesy of Charles Weitz,
Harvard Medical School), pre-Fos [37], pre-Dbp, pre- Rev-erba [38],
and RNA Polymerase II [39]. RT(2) controls in each PCR sample
used were negative. RT-qPCR products were quantified using the
comparative DCT method described previously [40].
Western blotting and Immunoprecipitations
Tissue samples were homogenized (1 min), triturated with an
18-gauge needle (1 min) and sonicated (2 sec) on ice in lysis buffer
containing 75 mM Hepes (pH 7.4), 1.5 mM EGTA, 150 mM
KCl, 1.5 mM MgCl2, 15% glycerol, 0.05% NP-40, and EDTA-
free complete protease inhibitor cocktail (Roche). This was
repeated twice and samples were then spun at 10,000 x g for 10
minutes at 4uC. The supernatant (lysate) was used for either
western blotting or immunoprecipitation (IP). For IP 200–300 mg
of protein was incubated on ice for 30 minutes with 50 mlo f
protein G beads or protein A beads conjugated to the appropriate
antibody DMP (Sigma). After spinning beads and protein lysates at
10,000 x g (10 min) at 4uC, the lysate was incubated on ice with
the appropriate IP antibody (30 min) while the beads were
washed. The cleared lysates, beads and antibodies were incubated,
rotating, overnight at 4uC, spun at 10,000 x g (30 sec) and washed
4 times with PBS. IPed complexes were eluded by boiling (10 min)
in 50 ml of 6X sample buffer followed by a spin (5 min) at 10,000 x
g. Twenty mg of total protein or 10–15 ml of immunoprecipitated
protein sample was loaded onto pre-cast 10% denaturing gels (Bio-
Rad) for all western blots. Transfers were with a small Genie
electrophoretic device (Idea Scientific, Minneapolis, MN) and
proteins were detected by ECL or by irradiance detection using an
Odyssey imaging system (LI-COR Biosciences).
Antibodies
We generated an antiserum against the C-terminal region of
USP2 in guinea pig (Covance) that recognizes both USP2a and
USP2b. Anti-Bmal1 antiserum (guinea pig) and PER1 (rabbit
1177) was kindly provided by Marina Antoch (Roswell Park
Cancer Institute, Buffalo, NY) and David Weaver (UMass Medical
Center, Worcester, MA) respectively. Other antibodies were
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anti-CK1e (rabbit, Abcam), anti-Cry1 (mouse, Alpha Diagnostics
International), anti-EGFR (rabbit, Abcam), anti-Per1 (rabbit,
Pierce), anti-USP2 (rabbit, Abgent), c-Tubulin (mouse, Abcam),
anti-Ubiquitin (rabbit, Thermo Scientific), anti-HA (rabbit, Santa
Cruz), anti-Flag (mouse, Sigma), and anti-c-MYC (mouse, Sigma).
Cell Culture and Transfection
A cDNA encoding mClock was provided by Charles Weitz
(Harvard Medical School), and mBmal1 and mPer2 cDNAs were
provided by Marina Antoch (Roswell Park Cancer Institute, Buffalo, NY).
mPer1 and HA-Ubiquitin cDNAs were purchased from Addgene.
The cDNA for mUsp2a and mUsp2b were cloned from mouse
(MGI:1858178). The Gateway cloning system (Invitrogen) was
used to clone the cDNAs into the pCMV-BICEP-4 bicistronic
vector (Sigma), which was converted to a Gateway destination
vector. All constructs were verified by sequencing and western
blotting following transient transfection in NIH3T3 or HEK293
cells obtained from the private ATCC Biology Collection.
NIH3T3 or HEK293 cells were cultured in DMEM (Sigma)
supplemented with 10% Cosmic serum, 4 mM L-glutamine,
1 mM sodium pyruvate, and 1% pen/strep were transfected at
approximately 80% confluency with Lipofectamine reagent
(Invitrogen) and Plus reagent (Invitrogen). For protein stability
assays HEK293 cells were transfected with 1 mg of either FLAG-
GFP/MYC-CLOCK, -BMAL1, or -PER1 and increasing
amounts (from 0 mgt o1 mg) of FLAG-USP2b/MYC-GFP.
Protein analysis was done 24 hours following transfection. For
protein turnover assays HEK293 cells at about 80% confluence
were transfected with a bicistronic vector expressing either FLAG-
USP2b/MYC- BMAL1, MYC-CLOCK, or MYC-PER1. Control
vectors included the same MYC-proteins with FLAG-GFP.
Cycloheximide (20 mg/ml) treatment began 24 hours following
transfection and extracts were western blotted 0, 1, 2, 4, and
8 hours later.
Statistical analyses
Usp2 rhythmicity at the level of the mRNA was tested using
one-way ANOVA. Two-way ANOVA was used to test differences
in phase shifts at various irradiances between wildtype and either
USP2
2/2, USP2
+/2, BMAL1
+/2, or USP2
+/2/BMAL1
+/2 mice
and phase shifts measured in mice of different genotype at specific
irradiance levels were compared to wildtype using an un-paired t-
test. Period measurements and activity counts were compared
between wildtype and USP2
2/2 mice using an un-paired t-test.
Two-way ANOVA was used to compare either mRNA or protein
expression over time between wildtype and USP2
2/2 mice.
GraphPad Prism software (GraphPad Software, Inc) was used for
both statistical analysis and plotting of quantitative data.
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